loading

Finanzdaten der Pulse Biosciences Inc-Aktie (PLSE)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Research and Development
13.57%
6.741
7.799 7.472 6.697 5.829
Costs And Expenses
15.30%
10.62
12.53 11.25 10.23 9.562
Operating Income/Loss
15.30%
-10.62
-12.53 -11.25 -10.23 -9.562
Nonoperating Income/Loss
20.33%
0.478
0.60 0.686 0.317 -0.239
Income/Loss From Continuing Operations Before Tax
15.05%
-10.14
-11.93 -10.57 -9.91 -9.801
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
15.05%
-10.14
-11.93 -10.57 -9.91 -9.801
Net Income/Loss
15.05%
-10.14
-11.93 -10.57 -9.91 -9.801
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,232%
55.17
2.366 54.92 44.51 37.39
Basic Earnings Per Share
18.18%
-0.18
-0.22 -0.19 -0.22 -0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.04
price up icon 0.14%
medical_instruments_supplies BAX
$33.31
price up icon 1.34%
$229.66
price up icon 0.76%
$79.44
price up icon 0.56%
medical_instruments_supplies COO
$103.43
price up icon 0.77%
medical_instruments_supplies WST
$323.32
price up icon 1.24%
Kapitalisierung:     |  Volumen (24h):